EQS-News: The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share
Source: EQS
Göttingen,
The Supervisory Board of a dividend of The Supervisory Board of This press release contains forward-looking statements about the future development of the Financial calendar A profile of Sartorius Sartorius is a leading international partner of life sciences research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. The Bioprocess Solutions division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and economically. The company, based in Göttingen, Contact +49 (0)551.308.4724 timo.lindemann@sartorius.com Additional features: File: Media Release
|
Language: | English |
Company: | |
Otto-Brenner-Straße 20 | |
37079 Göttingen | |
Phone: | +49.(0)551-308.0 |
Fax: | +49.(0)551-308.3289 |
E-mail: | info@sartorius.com |
Internet: | www.sartorius.com |
ISIN: | DE0007165607, DE0007165631 |
WKN: | 716560 , 716563 |
Indices: | DAX, TecDAX |
Listed: | Regulated Market in |
EQS News ID: | 1834613 |
End of News |
|
1834613 09.02.2024 CET/CEST